Artiva Biotherapeutics shareholders vote to expand 2024 equity incentive plan share pool by 5,097,095 shares
ARTV•Shareholders approve equity plan expansion
Artiva Biotherapeutics held its annual stockholder meeting on Sept. 8, 2026.
ARTV•ARTV•ARTV•Artiva Biotherapeutics held its annual stockholder meeting on Sept. 8, 2026.
Stockholders backed an amendment to the 2024 Equity Incentive Plan, lifting the share pool by 5,097,095 shares.
The plan change was also set to count shares issuable on pre-funded warrants in the annual automatic share reserve increase calculation.
Investors ratified KPMG as independent registered public accounting firm for the fiscal year ending Dec. 31, 2026.
